📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-05 13:46
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
Rs 5.50 Cr PAT: Jaysynth Orgochem Q1 Profit Jumps 220% YoY Despite Flat Revenue
Jaysynth Orgochem reported a strong bottom-line performance for Q1 FY27, with consolidated PAT surging 220% YoY to Rs 5.50 Cr from Rs 1.72 Cr. This growth was driven by a sharp margin expansion in the core Colorants & Chemicals segment, where profits rose to Rs 7.48 Cr from Rs 3.02 Cr YoY. However, consolidated revenue remained stagnant at Rs 58.13 Cr (down 1.5% YoY) and fell 16.3% sequentially from Q4 FY26. The Inkjet Printers segment remains a drag, reporting a loss of Rs 26.37 lakhs for the quarter.
Confidence: HIGH
What changedThe company has significantly improved its profitability through better margins in its core segment and is expanding its international footprint with a new Hong Kong subsidiary.
Why it mattersThe massive profit growth despite flat revenue suggests a successful shift toward higher-margin product realizations, which is critical for a specialty chemicals player with a small market cap of Rs 183 Cr.
Consolidated PAT (Q1): Rs 5.50 CrYoY PAT Growth: 220%Q1 Revenue vs TTM Revenue: 22.4%Colorants Segment Profit: Rs 7.48 CrInkjet Segment Loss: Rs 0.26 Cr
📅 Short termThe stock may react positively to the substantial YoY profit growth and the expansion of the bottom line despite a challenging revenue environment.
📈 Long termThe company's ability to sustain these higher margins and successfully scale its digital ink business will be the primary driver for long-term re-rating.
⚠ Risk flags
- Sequential revenue decline of 16.3%
- Loss-making Inkjet Printers segment
- High dependency on crude oil derivative costs
Key Highlights
Consolidated Net Profit grew 220% YoY to Rs 5.50 Cr in Q1 FY27.
Revenue from operations stood at Rs 58.13 Cr, representing ~22.4% of TTM revenue.
Colorants & Chemicals segment profit more than doubled to Rs 7.48 Cr from Rs 3.02 Cr YoY.
Inkjet Printers segment reported a loss of Rs 26.37 lakhs on revenue of Rs 3.14 Cr.
Incorporated a new wholly-owned subsidiary, VarnaTex Limited, in Hong Kong with 500,000 HKD capital.
👀 What to Watch
Watch for the operational commencement of the new Hong Kong subsidiary and monitor if the Inkjet segment can reach break-even, as it currently offsets gains from the core chemicals business.
